8-K: Actelis Networks Secures $1.6M via Discounted Warrant Exercise

Actelis Networks, Inc. completed an inducement agreement to accelerate warrant exercises at a reduced price, raising approximately $1.6 million in gross proceeds.

Summary

• Actelis Networks, Inc. entered into an inducement agreement on September 2, 2025, with a holder of existing warrants to purchase 4,270,197 shares of common stock.
• The holder agreed to exercise these existing warrants for cash at a reduced price of $0.37 per share, significantly lower than their original exercise prices of $1.18, $2.00, and $1.75.
• In consideration, the Company will issue new common stock purchase warrants (New Warrants) for up to 6,405,296 shares at an exercise price of $0.37 per share.
• The Company expects to receive approximately $1.6 million in gross proceeds from the exercise of the existing warrants.
• Financial advisory fees include a 7.0% cash fee and a 1.0% management fee (total 8.0%) of the gross proceeds, plus up to $75,000 for non-accountable expenses and $15,950 for clearing fees.
• Placement Agent Warrants to purchase 298,914 shares (7.0% of exercised existing warrants) will be issued to financial advisors with an exercise price of $0.4625 per share and a five-year term.
• The closing of these transactions occurred on September 3, 2025, with net proceeds intended for general corporate purposes.
• The number of common shares outstanding increased from 11,292,114 to 12,545,117 after giving effect to the transaction, with 3,017,197 shares held in abeyance due to beneficial ownership limitations.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the significant discount offered to induce warrant exercises, implying a weak stock performance or urgent need for capital. High fees and substantial potential dilution further contribute to a negative outlook, outweighing the benefit of immediate cash infusion.

Positives

• Secured approximately $1.6 million in gross proceeds, providing immediate capital for general corporate purposes.
• Accelerated the exercise of existing warrants, converting potential future capital into current cash flow.

Negatives

• Existing warrants were exercised at a significantly reduced price of $0.37 per share, substantially lower than their original exercise prices ($1.18, $2.00, $1.75), indicating a deep discount.
• The transaction involves significant dilution, with shares outstanding increasing immediately and potential for further dilution from the issuance of 6,405,296 New Warrants and 298,914 Placement Agent Warrants.
• High financial advisory fees totaling 8.0% of gross proceeds in cash, plus additional warrants and expenses, reduce the net proceeds received by the Company.
• Restrictions on issuing common stock or equivalents and filing other registration statements for 15 days post-closing, and a one-year prohibition on Variable Rate Transactions, limit future financing flexibility.

Risks

• The exercisability of the New Warrants is contingent upon obtaining Stockholder Approval, which the Company has committed to seek within 90 days of the closing date.
• The New Warrants and Placement Agent Warrants have not been registered under the Securities Act, relying on an exemption, which may affect their liquidity and transferability.
• There is no established trading market for the New Warrants, and the Company does not expect one to develop, limiting their liquidity.
• Beneficial ownership limitations may delay the full issuance of shares from the exercise of existing warrants, with 3,017,197 shares currently held in abeyance.

Future Outlook

The Company expects to use the net proceeds from these transactions for general corporate purposes. It has committed to filing a registration statement for the resale of the New Warrant Shares and to hold a stockholder meeting within 90 days of the closing date to obtain approval for the issuance of the New Warrants.

Management Comments

• Tuvia Barlev, Chief Executive Officer, signed the report on behalf of Actelis Networks, Inc.

Industry Context

This transaction is a company-specific financing event aimed at raising capital through the inducement of warrant exercises. It reflects the company's immediate capital needs and its strategy to convert outstanding warrants into cash, potentially indicating a challenging market environment for traditional equity raises or a need to shore up working capital.

Comparison to Industry Standards

• The significant reduction in the exercise price of existing warrants (from $1.18-$2.00 to $0.37) is a strong indicator of a distressed capital raise, often seen in companies facing liquidity challenges or whose stock price has significantly underperformed.
• The combined cash and warrant fees for financial advisors (8.0% cash plus 7.0% in warrants) are on the higher end for capital raises, particularly for a relatively small amount, suggesting a less favorable negotiating position for the Company compared to industry benchmarks for healthy companies.
• The issuance of new warrants at 150% of the exercised existing warrants, coupled with the low exercise price, points to substantial future dilution, which is generally viewed negatively by investors unless there is a clear, high-growth use of proceeds that can offset this dilution.

Corporate Governance

Stakeholder Impact

• Shareholders: Will experience immediate dilution from the exercise of existing warrants and potential further dilution from the New Warrants and Placement Agent Warrants. The reduced exercise price for existing warrants suggests a lower valuation for the company's equity.
• Warrant Holders (Existing): Benefited from a significantly reduced exercise price, allowing them to convert their warrants into common stock at a favorable rate and receive new warrants as an incentive.
• Financial Advisors: Received substantial cash fees (8.0% of gross proceeds) and Placement Agent Warrants, indicating a significant cost to the Company for this capital raise.
• Company (Actelis Networks, Inc.): Gained immediate capital of approximately $1.6 million (gross) for general corporate purposes, but at the cost of significant dilution and high transaction expenses.

Next Steps

• The Company will file a registration statement on Form S-1 (or other appropriate form) for the resale of the New Warrant Shares as soon as practicable, and in any event within thirty (30) calendar days of Stockholder Approval.
• The Company will use commercially reasonable efforts to have the Resale Registration Statement declared effective by the SEC within sixty (60) calendar days (or ninety (90) days in case of full review) following Stockholder Approval.
• The Company will hold a meeting of its stockholders on or prior to ninety (90) days following the Closing Date (September 3, 2025) to obtain Stockholder Approval for the issuance of the New Warrants.

Key Dates

Recommendation

The terms of this capital raise are highly unfavorable for existing shareholders, indicating potential financial distress or a very weak market position for Actelis Networks. The deep discount on warrant exercise prices, coupled with substantial dilution from new warrants and high advisory fees, suggests the Company is raising capital at a significant cost. This type of financing often precedes further stock price declines as the market digests the dilution and the implications of such terms. Investors should consider selling to avoid further potential losses.

Keywords

Actelis Networks, ASNS, Warrant Exercise, Inducement Agreement, Capital Raise, Equity Financing, SEC Filing, Dilution, Common Stock, Nasdaq Capital Market